207 related articles for article (PubMed ID: 37178730)
21. [THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS].
Murakami Y; Sugiyama A; Ideguchi H; Murakami Y; Amimoto Y; Nishie H; Odajima H
Arerugi; 2020; 69(3):213-217. PubMed ID: 32435023
[TBL] [Abstract][Full Text] [Related]
22. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
[TBL] [Abstract][Full Text] [Related]
23. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
24. Chronic hemicorporal prurigo related to a posttraumatic Brown-Séquard syndrome.
Thielen AM; Vokatch N; Borradori L
Dermatology; 2008; 217(1):45-7. PubMed ID: 18367840
[TBL] [Abstract][Full Text] [Related]
25. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis.
Alkon N; Assen FP; Arnoldner T; Bauer WM; Medjimorec MA; Shaw LE; Rindler K; Holzer G; Weber P; Weninger W; Freystätter C; Chennareddy S; Kinaciyan T; Farlik M; Jonak C; Griss J; Bangert C; Brunner PM
J Allergy Clin Immunol; 2023 Aug; 152(2):420-435. PubMed ID: 37210042
[TBL] [Abstract][Full Text] [Related]
26. Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment.
Wong LS; Yen YT
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293248
[TBL] [Abstract][Full Text] [Related]
27. Relieving the pruritus of atopic dermatitis: a meta-analysis.
Sher LG; Chang J; Patel IB; Balkrishnan R; Fleischer AB
Acta Derm Venereol; 2012 Sep; 92(5):455-61. PubMed ID: 22773026
[TBL] [Abstract][Full Text] [Related]
28. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
[TBL] [Abstract][Full Text] [Related]
29. S2k guideline: Diagnosis and treatment of chronic pruritus.
Ständer S; Zeidler C; Augustin M; Darsow U; Kremer AE; Legat FJ; Koschmieder S; Kupfer J; Mettang T; Metz M; Nast A; Raap U; Schneider G; Ständer H; Streit M; Schut C; Weisshaar E
J Dtsch Dermatol Ges; 2022 Oct; 20(10):1387-1402. PubMed ID: 36252071
[TBL] [Abstract][Full Text] [Related]
30. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
31. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Tsianakas A; Zeidler C; Riepe C; Borowski M; Forner C; Gerss J; Metz M; Staubach P; Raap U; Kaatz M; Urban M; Luger TA; Ständer S
Acta Derm Venereol; 2019 Apr; 99(4):379-385. PubMed ID: 30653242
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the effects on pruritus by novel treatments for atopic dermatitis.
Bonnekoh H; Butze M; Metz M
J Dtsch Dermatol Ges; 2022 Feb; 20(2):150-156. PubMed ID: 34958173
[TBL] [Abstract][Full Text] [Related]
33. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.
Napolitano M; Fabbrocini G; Scalvenzi M; Nisticò SP; Dastoli S; Patruno C
Dermatitis; 2020; 31(1):81-84. PubMed ID: 31517666
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of pruritus in prurigo nodularis.
Shao Y; Wang D; Zhu Y; Xiao Z; Jin T; Peng L; Shen Y; Tang H
Front Immunol; 2023; 14():1301817. PubMed ID: 38077377
[TBL] [Abstract][Full Text] [Related]
36. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis.
Janmohamed SR; Gwillim EC; Yousaf M; Patel KR; Silverberg JI
Arch Dermatol Res; 2021 Oct; 313(8):669-677. PubMed ID: 33108524
[TBL] [Abstract][Full Text] [Related]
37. Chronic prurigo.
Misery L
Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of biologics in prurigo nodularis.
Müller S; Bieber T; Ständer S
Expert Opin Biol Ther; 2022 Jan; 22(1):47-58. PubMed ID: 34289753
[TBL] [Abstract][Full Text] [Related]
40. Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
Frølunde AS; Wiis MAK; Ben Abdallah H; Elsgaard S; Danielsen AK; Deleuran M; Vestergaard C
Dermatology; 2022; 238(5):950-960. PubMed ID: 35417906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
